Key Stats
- Founded: January 20, 1934 in Minami-Ashigara, Japan
- Headquarters: Tokyo, Japan
- Employees: 72,593 (March 2025)
- Revenue: ¥3.2 trillion / $21 billion (FY 2025)
- Market Cap: $23-27 billion (2025)
Fujifilm Holdings Corporation is a Japanese multinational conglomerate headquartered in Tokyo. The company began as a photographic film manufacturer in 1934 and has since transformed into a diversified technology company operating across healthcare, materials, business innovation, and imaging sectors.
While Eastman Kodak filed for bankruptcy in 2012 after failing to adapt to digital photography, Fujifilm successfully pivoted its business model. The company now generates over 30% of its revenue from healthcare, including medical imaging equipment, pharmaceuticals, and biopharmaceutical contract manufacturing.
Fujifilm trades on the Tokyo Stock Exchange under ticker 4901 and on US OTC markets as FUJIY. The company operates through two main subsidiaries: FUJIFILM Corporation and FUJIFILM Business Innovation Corporation (formerly Fuji Xerox).
Fujifilm Holdings History
Fuji Photo Film Co., Ltd. established as a subsidiary of Daicel (then Dainippon Celluloid Company). Shuichi Asano named first president. The company began producing photographic films, motion picture films, and X-ray films at its Ashigara Factory.
Fuji Photo entered the optical glasses, lenses, and equipment markets. After World War II, the company diversified into medical X-ray diagnosis, printing, electronic imaging, and magnetic materials.
Fuji Photo and UK-based Rank Xerox Limited launched Fuji Xerox Co., Ltd. through a joint venture, entering the document solutions market.
Fuji Photo expanded production facilities overseas and developed digital technologies for photography, medical, and printing sectors. The company invented computed radiography (CR), reducing radiation exposure for patients and technicians.
Fuji became a title sponsor of the Los Angeles Olympics, gaining significant US market share against Kodak by offering cheaper camera film and establishing a US manufacturing facility.
Fujifilm Holdings Corporation established as a holding company. FUJIFILM Corporation and Fuji Xerox became wholly owned subsidiaries. Headquarters relocated to Tokyo Midtown in 2007.
Fujifilm acquired Toyama Chemical Co., Ltd., adding pharmaceutical capabilities including the antiviral drug favipiravir (Avigan).
Fujifilm acquired SonoSite for $995 million, entering the point-of-care ultrasound market. The same year, rival Eastman Kodak filed for bankruptcy.
Fujifilm acquired Xerox’s 25% stake in Fuji Xerox, making it a wholly owned subsidiary. Also acquired Hitachi’s diagnostic imaging business for $1.63 billion.
Fuji Xerox renamed to FUJIFILM Business Innovation Corporation. Teiichi Goto became President and CEO. Shigetaka Komori, who led the company’s transformation since 2000, became executive adviser.
Fujifilm Holdings Founders and Early Leadership
Shuichi Asano
First President of Fuji Photo Film Co., Ltd. Asano led the company from its 1934 founding, overseeing early production of photographic films, motion picture films, and dry plates.
Daicel Corporation (Dainippon Celluloid)
Parent company that spun off its photographic division to create Fuji Photo Film. Provided initial capital and manufacturing expertise for Japan’s first domestic photographic film producer.
Shigetaka Komori
CEO from 2000 to 2021 who transformed Fujifilm from a film company into a diversified technology conglomerate. Author of “Innovating Out of a Crisis” (2015). Now serves as executive adviser.
Teiichi Goto
Current President and CEO since June 2021. Previously served as General Manager of the Medical Systems Business Division and has been with the company since 2018 as Director.
Fujifilm Holdings Revenue
Fujifilm Holdings generated ¥3.2 trillion (approximately $21 billion) in revenue for fiscal year 2025, representing 7.9% growth from the previous year. Healthcare now accounts for the largest revenue segment, followed by materials, business innovation, and imaging.
The company has maintained steady revenue growth despite the collapse of its traditional film business. Japan remains the largest market at 34.4% of total revenue, followed by Asia and other regions at 28.3%, the Americas, and Europe.
Fujifilm Holdings Market Cap
Fujifilm Holdings has a market capitalization of approximately $23-27 billion as of 2025-2026. The company trades on the Tokyo Stock Exchange (4901) and US OTC markets (FUJIY). Market cap has grown at a compound annual rate of about 2.5% since 1992.
The stock price reflects investor confidence in Fujifilm’s diversification strategy, particularly its expansion into healthcare and semiconductor materials. The company ranks among the top 900 most valuable companies globally.
Fujifilm Holdings Acquisitions
Fujifilm Holdings has completed over a dozen acquisitions since its transformation began in the early 2000s. These acquisitions focused primarily on healthcare, life sciences, and advanced materials, allowing the company to reduce dependence on its declining photographic film business.
The acquisition of Toyama Chemical in 2008 gave Fujifilm pharmaceutical manufacturing capabilities and the antiviral drug favipiravir. This drug gained attention during the COVID-19 pandemic as a potential treatment option and was approved in several countries including China, Russia, and Indonesia.
In 2011, Fujifilm acquired biopharmaceutical contract manufacturing operations from Merck & Co., forming the foundation of Fujifilm Diosynth Biotechnologies. This unit has since become the world’s second-largest biopharmaceutical contract manufacturer after Lonza of Switzerland.
The 2012 acquisition of SonoSite for $995 million marked Fujifilm’s entry into the point-of-care ultrasound market. SonoSite specializes in portable ultrasound devices used in emergency medicine, surgery, and critical care. This deal remains Fujifilm’s largest single acquisition.
Fujifilm expanded its life sciences portfolio through acquisitions of Irvine Scientific and Cellular Dynamics, a leader in iPSC (induced pluripotent stem cell) research and manufacturing. The 2019 acquisition of Hitachi’s diagnostic imaging business for $1.63 billion further strengthened Fujifilm’s medical imaging capabilities.
The company also made strategic acquisitions in printing and materials, including Sericol Ltd. (UK-based printing ink company) in 2005 and KMG Chemicals (electronic and wood treating chemicals) in 2023. These acquisitions support Fujifilm’s semiconductor materials and graphic communications businesses.
Fujifilm Holdings Competitors
Fujifilm Holdings competes across multiple industries including imaging, healthcare, and advanced materials. In the camera market, Fujifilm’s X-series and GFX medium format cameras compete with Sony, Canon, and Nikon. The company’s Instax instant camera line dominates that market with approximately 70% share.
| Competitor | Headquarters | Primary Overlap |
|---|---|---|
| Canon Inc. | Tokyo, Japan | Cameras, Medical Imaging, Office Equipment |
| Sony Corporation | Tokyo, Japan | Digital Cameras, Image Sensors |
| Nikon Corporation | Tokyo, Japan | Cameras, Optical Equipment, Medical Imaging |
| Siemens Healthineers | Erlangen, Germany | Diagnostic Imaging, Medical Equipment |
| GE HealthCare | Chicago, USA | Medical Imaging, Diagnostics |
| Olympus Corporation | Tokyo, Japan | Endoscopes, Medical Equipment |
| Lonza Group | Basel, Switzerland | Biopharmaceutical Manufacturing |
| Thermo Fisher Scientific | Waltham, USA | Life Sciences, CDMO Services |
| Konica Minolta | Tokyo, Japan | Office Equipment, Medical Imaging |
| Shin-Etsu Chemical | Tokyo, Japan | Semiconductor Materials |
FAQs
When was Fujifilm Holdings founded?
Fujifilm was founded on January 20, 1934, as Fuji Photo Film Co., Ltd. in Minami-Ashigara, Japan. The company was established as a subsidiary of Dainippon Celluloid Company to produce Japan’s first domestic photographic films.
Who is the current CEO of Fujifilm Holdings?
Teiichi Goto has served as President, Representative Director, and CEO of Fujifilm Holdings since June 2021. He previously led the Medical Systems Business Division and succeeded Shigetaka Komori who transformed the company.
What happened to Fujifilm’s film business?
Fujifilm’s photographic film business declined over 90% from its peak around 2000 due to digital photography. The company adapted by diversifying into healthcare, materials, and other technology sectors while Kodak filed bankruptcy in 2012.
How many employees does Fujifilm Holdings have?
Fujifilm Holdings employs approximately 72,593 people worldwide as of March 2025. The company operates through over 300 subsidiaries globally, with major facilities in Japan, the United States, Europe, and Asia.
What is Fujifilm Holdings market cap?
Fujifilm Holdings has a market capitalization of approximately $23-27 billion USD as of 2025-2026. The company trades on the Tokyo Stock Exchange (ticker 4901) and US OTC markets (FUJIY).